CERS:NASDAQ
Cerus Corp
$2.30
arrow_upward
+0.88%(+0.020) 1D
$2.30
0.00% (0.00)
bedtimeAfter hours
Closed: Oct 9, 4:00:01 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CERS...
Open
$2.31
High
$2.33
Low
$2.27
Mkt. cap
463.51M
Avg. vol.
1.65M
Volume
787.97K
52-wk high
$3.47
52-wk low
$1.38
EPS
-$0.03
Beta
1.83
Shares outstanding
201.52M
No. of employees
268
Open
$2.31
High
$2.33
Low
$2.27
Mkt. cap
463.51M
Avg. vol.
1.65M
Volume
787.97K
52-wk high
$3.47
52-wk low
$1.38
EPS
-$0.03
Beta
1.83
Shares outstanding
201.52M
No. of employees
268
News stories
From web sources and news partners
AskTraders.com
·
21 minutes ago
S&P 500: Why UBS Says Investors Should ‘Stay Invested Near Record Highs’
Yahoo Finance
·
1 hour ago
Beyond S&P 500 Index Funds: Here's the 1 Sector I'd Buy First as a New Investor
Benzinga
·
1 hour ago
Dow Jones, S&P 500, Nasdaq 100 Outlook: Top Stock Market News This Week
24/7 Wall St.
·
5 hours ago
KLA Turned $1,000 Into $31,595 in a Decade, Crushing the S&P 500 by 8.7x
Profile
Cerus Corporation is an American multinational biotechnology company headquartered in Concord, California that develops and provides a treatment system to pathogen-reduce human blood products for the healthcare industry. Wikipedia
About Cerus Corp
CEO-
Employees268
FoundedSep 1991
HeadquartersConcord, California, United States
SectorMedical device
Websitecerus.com